Employees
~100
Stage
Commercial
Modalities
OtherSmall molecule

Dow Pharmaceutical Sciences General Information

Specialized dermatology R&D organization focused on topical product development. Successfully developed Acanya (clindamycin phosphate + benzoyl peroxide) for acne. Acquired by Valeant in 2008.

Contact Information

Website
Primary Industry
CRO
Corporate Office

Drug Pipeline

clindamycin phosphate + benzoyl peroxide
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Dow Pharmaceutical Sciences's pipeline data

Book a demo

Key Partnerships

Multiple pharmaceutical and biotechnology companies (unspecified)

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Dow Pharmaceutical Sciences Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Dow Pharmaceutical Sciences's complete valuation and funding history, request access ยป